Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma.

Chua V, Orloff M, Teh JL, Sugase T, Liao C, Purwin TJ, Lam BQ, Terai M, Ambrosini G, Carvajal RD, Schwartz G, Sato T, Aplin AE.

EMBO Mol Med. 2019 Jan 4. pii: e9081. doi: 10.15252/emmm.201809081. [Epub ahead of print]

2.

Effects of Oncogenic Gαq and Gα11 Inhibition by FR900359 in Uveal Melanoma.

Lapadula D, Farias E, Randolph CE, Purwin T, McGrath D, Charpentier T, Zhang L, Wu S, Terai M, Sato T, Tall GG, Zhou N, Wedegaertner P, Aplin AE, Aguirre-Ghiso J, Benovic JL.

Mol Cancer Res. 2018 Dec 19. pii: molcanres.0574.2018. doi: 10.1158/1541-7786.MCR-18-0574. [Epub ahead of print]

PMID:
30567972
3.

A pediatric case of anaphylactic shock induced by tipepidine hibenzate (Asverin).

Takai H, Kato I, Mitsunaga K, Hara M, Kodama T, Kanazawa M, Terai M.

Asia Pac Allergy. 2018 Oct 18;8(4):e37. doi: 10.5415/apallergy.2018.8.e37. eCollection 2018 Oct.

4.

Quantitative fluorescence in situ hybridization for investigation of telomere length dynamics in the pituitary gland using samples from 128 autopsied patients.

Hiraishi N, Terai M, Fujiwara M, Aida J, Izumiyama-Shimomura N, Ishikawa N, Tomita KI, Matsuda Y, Arai T, Takubo K, Ishiwata T.

Tissue Cell. 2018 Aug;53:1-7. doi: 10.1016/j.tice.2018.05.008. Epub 2018 May 19.

PMID:
30060819
5.

Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.

Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N, Fuse S, Hamaoka K, Hirono K, Kato T, Mitani Y, Sato S, Shimoyama S, Shiono J, Suda K, Suzuki H, Maeda J, Waki K; and The Z-score Project 2nd Stage Study Group, Kato H, Saji T, Yamagishi H, Ozeki A, Tomotsune M, Yoshida M, Akazawa Y, Aso K, Doi S, Fukasawa Y, Furuno K, Hayabuchi Y, Hayashi M, Honda T, Horita N, Ikeda K, Ishii M, Iwashima S, Kamada M, Kaneko M, Katyama H, Kawamura Y, Kitagawa A, Komori A, Kuraishi K, Masuda H, Matsuda S, Matsuzaki S, Mii S, Miyamoto T, Moritou Y, Motoki N, Nagumo K, Nakamura T, Nishihara E, Nomura Y, Ogata S, Ohashi H, Okumura K, Omori D, Sano T, Suganuma E, Takahashi T, Takatsuki S, Takeda A, Terai M, Toyono M, Watanabe K, Watanabe M, Yamamoto M, Yamamura K.

JAMA Pediatr. 2018 May 7;172(5):e180030. doi: 10.1001/jamapediatrics.2018.0030. Epub 2018 May 7.

6.

PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma.

Javed A, Arguello D, Johnston C, Gatalica Z, Terai M, Weight RM, Orloff M, Mastrangelo MJ, Sato T.

Immunotherapy. 2017 Dec;9(16):1323-1330. doi: 10.2217/imt-2017-0066.

PMID:
29185395
7.

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma.

Krepler C, Sproesser K, Brafford P, Beqiri M, Garman B, Xiao M, Shannan B, Watters A, Perego M, Zhang G, Vultur A, Yin X, Liu Q, Anastopoulos IN, Wubbenhorst B, Wilson MA, Xu W, Karakousis G, Feldman M, Xu X, Amaravadi R, Gangadhar TC, Elder DE, Haydu LE, Wargo JA, Davies MA, Lu Y, Mills GB, Frederick DT, Barzily-Rokni M, Flaherty KT, Hoon DS, Guarino M, Bennett JJ, Ryan RW, Petrelli NJ, Shields CL, Terai M, Sato T, Aplin AE, Roesch A, Darr D, Angus S, Kumar R, Halilovic E, Caponigro G, Jeay S, Wuerthner J, Walter A, Ocker M, Boxer MB, Schuchter L, Nathanson KL, Herlyn M.

Cell Rep. 2017 Nov 14;21(7):1953-1967. doi: 10.1016/j.celrep.2017.10.021.

8.

Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.

Kageyama K, Ohara M, Saito K, Ozaki S, Terai M, Mastrangelo MJ, Fortina P, Aplin AE, Sato T.

J Transl Med. 2017 Jun 23;15(1):145. doi: 10.1186/s12967-017-1247-z.

9.

Comprehensive pathogen detection associated with four recurrent episodes of Kawasaki disease in a patient during a single year using next-generation sequencing.

Hamada H, Sekizuka T, Oba K, Katano H, Kinumaki A, Terai M, Mizutani T, Kuroda M.

JMM Case Rep. 2016 Feb 1;3(1):e005019. doi: 10.1099/jmmcr.0.005019. eCollection 2016 Feb.

10.

Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma.

Cheng H, Chua V, Liao C, Purwin TJ, Terai M, Kageyama K, Davies MA, Sato T, Aplin AE.

Mol Cancer Ther. 2017 Mar;16(3):516-528. doi: 10.1158/1535-7163.MCT-16-0552. Epub 2017 Jan 30.

11.

Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment.

Kemp DM, Pidich A, Larijani M, Jonas R, Lash E, Sato T, Terai M, De Pizzol M, Allegretti M, Igoucheva O, Alexeev V.

Oncotarget. 2017 Feb 28;8(9):14428-14442. doi: 10.18632/oncotarget.14803.

12.

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells.

Terai M, Mu Z, Eschelman DJ, Gonsalves CF, Kageyama K, Chervoneva I, Orloff M, Weight R, Mastrangelo MJ, Cristofanilli M, Sato T.

EBioMedicine. 2015 Sep 18;2(11):1821-6. doi: 10.1016/j.ebiom.2015.09.019. eCollection 2015 Nov.

13.

Variations in ORAI1 Gene Associated with Kawasaki Disease.

Onouchi Y, Fukazawa R, Yamamura K, Suzuki H, Kakimoto N, Suenaga T, Takeuchi T, Hamada H, Honda T, Yasukawa K, Terai M, Ebata R, Higashi K, Saji T, Kemmotsu Y, Takatsuki S, Ouchi K, Kishi F, Yoshikawa T, Nagai T, Hamamoto K, Sato Y, Honda A, Kobayashi H, Sato J, Shibuta S, Miyawaki M, Oishi K, Yamaga H, Aoyagi N, Yoshiyama M, Miyashita R, Murata Y, Fujino A, Ozaki K, Kawasaki T, Abe J, Seki M, Kobayashi T, Arakawa H, Ogawa S, Hara T, Hata A, Tanaka T.

PLoS One. 2016 Jan 20;11(1):e0145486. doi: 10.1371/journal.pone.0145486. eCollection 2016.

14.

Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial).

Aoyagi R, Hamada H, Sato Y, Suzuki H, Onouchi Y, Ebata R, Nagashima K, Terauchi M, Terai M, Hanaoka H, Hata A; KAICA Trial Investigators.

BMJ Open. 2015 Dec 1;5(12):e009562. doi: 10.1136/bmjopen-2015-009562.

15.

Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization.

Ozaki S, Vuyyuru R, Kageyama K, Terai M, Ohara M, Cheng H, Manser T, Mastrangelo MJ, Aplin AE, Sato T.

Am J Pathol. 2016 Jan;186(1):43-56. doi: 10.1016/j.ajpath.2015.09.011. Epub 2015 Nov 25.

16.

Disrupted glutamate-glutamine cycle in acute encephalopathy with biphasic seizures and late reduced diffusion.

Takanashi J, Mizuguchi M, Terai M, Barkovich AJ.

Neuroradiology. 2015 Nov;57(11):1163-8. doi: 10.1007/s00234-015-1573-x. Epub 2015 Aug 23.

PMID:
26298309
17.

Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma.

Cheng H, Terai M, Kageyama K, Ozaki S, McCue PA, Sato T, Aplin AE.

Cancer Res. 2015 Jul 1;75(13):2737-48. doi: 10.1158/0008-5472.CAN-15-0370. Epub 2015 May 7.

18.

Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases.

Valsecchi ME, Terai M, Eschelman DJ, Gonsalves CF, Chervoneva I, Shields JA, Shields CL, Yamamoto A, Sullivan KL, Laudadio M, Berd D, Mastrangelo MJ, Sato T.

J Vasc Interv Radiol. 2015 Apr;26(4):523-32.e2. doi: 10.1016/j.jvir.2014.11.037. Epub 2015 Feb 9.

19.

Arm-specific telomere dynamics of each individual chromosome in induced pluripotent stem cells revealed by quantitative fluorescence in situ hybridization.

Terai M, Izumiyama-Shimomura N, Aida J, Ishikawa N, Kuroiwa M, Arai T, Toyoda M, Nakamura K, Takubo K.

Tissue Cell. 2014 Dec;46(6):470-6. doi: 10.1016/j.tice.2014.08.005. Epub 2014 Aug 27.

PMID:
25217290
20.

[Epidemiological study of respiratory viruses detected in patients under two years old who required admission because of lower respiratory disease].

Hamada H, Ogura A, Hotta C, Wakui T, Ogawa T, Terai M.

Kansenshogaku Zasshi. 2014 Jul;88(4):423-9. Japanese.

PMID:
25199375
21.

Phototropin encoded by a single-copy gene mediates chloroplast photorelocation movements in the liverwort Marchantia polymorpha.

Komatsu A, Terai M, Ishizaki K, Suetsugu N, Tsuboi H, Nishihama R, Yamato KT, Wada M, Kohchi T.

Plant Physiol. 2014 Sep;166(1):411-27. doi: 10.1104/pp.114.245100. Epub 2014 Aug 5.

22.

Pneumothorax in patients with severe combined immunodeficiency.

Hoshino A, Imai K, Ohshima Y, Yasutomi M, Kasai M, Terai M, Ishigaki K, Morio T, Miyawaki T, Kanegane H.

Pediatr Int. 2014 Aug;56(4):510-4. doi: 10.1111/ped.12325. Epub 2014 May 30. Erratum in: Pediatr Int. 2014 Dec;56(6):941. Pediatr Int. 2014 Dec;56(6):941.

PMID:
24612091
23.

Characteristic systemic cytokine responses in children with human bocavirus-positive lower respiratory tract infection.

Hirose Y, Hamada H, Wakui T, Ogawa T, Terai M.

Microbiol Immunol. 2014 Mar;58(3):215-8. doi: 10.1111/1348-0421.12145. Erratum in: Microbiol Immunol. 2015 Oct;59(10):641.

24.

Hypohidrosis plays a crucial role in the vicious circle of bathing suit ichthyosis: a case with summer exacerbation.

Washio K, Fukunaga A, Terai M, Hitomi K, Yamanishi K, Nishigori C.

Acta Derm Venereol. 2014 May;94(3):349-50. doi: 10.2340/00015555-1739. No abstract available.

25.

Association of telomere shortening in myocardium with heart weight gain and cause of death.

Terai M, Izumiyama-Shimomura N, Aida J, Ishikawa N, Sawabe M, Arai T, Fujiwara M, Ishii A, Nakamura K, Takubo K.

Sci Rep. 2013;3:2401. doi: 10.1038/srep02401.

26.

Investigation of telomere length dynamics in induced pluripotent stem cells using quantitative fluorescence in situ hybridization.

Terai M, Izumiyama-Shimomura N, Aida J, Ishikawa N, Kuroiwa M, Poon SS, Arai T, Toyoda M, Akutsu H, Umezawa A, Nakamura K, Takubo K.

Tissue Cell. 2013 Dec;45(6):407-13. doi: 10.1016/j.tice.2013.07.003. Epub 2013 Aug 5.

PMID:
23928219
27.

WU polyomavirus detected in respiratory tract specimens from young children in Japan.

Okada M, Hamada H, Sato-Maru H, Shirato Y, Honda T, Muto A, Hayashi K, Terai M.

Pediatr Int. 2013 Aug;55(4):536-7. doi: 10.1111/ped.12147.

PMID:
23724787
28.

Telomere shortening in the esophagus of Japanese alcoholics: relationships with chromoendoscopic findings, ALDH2 and ADH1B genotypes and smoking history.

Aida J, Yokoyama A, Shimomura N, Nakamura K, Ishikawa N, Terai M, Poon S, Matsuura M, Fujiwara M, Sawabe M, Arai T, Takubo K.

PLoS One. 2013 May 7;8(5):e63860. doi: 10.1371/journal.pone.0063860. Print 2013.

29.

[Patient safety and quality of medical care. Topics: II. Measurement and improvement of quality of medical care; 3. Improvement of medical care: experiences of a teaching hospital in Tokyo].

Fukui T, Shimada G, Wakita N, Horikawa C, Terai M, Ohde S, Komatsu Y.

Nihon Naika Gakkai Zasshi. 2012 Dec 10;101(12):3432-9. Japanese. No abstract available.

PMID:
23356161
30.

[Patient safety and quality of medical care. Topics: I. Incident and accident in hospital: Current situation; 4. Accidental falls and prevention program among inpatients].

Ohde S, Terai M, Takahashi O, Oizumi A, Takekata M, Fukui T.

Nihon Naika Gakkai Zasshi. 2012 Dec 10;101(12):3396-403. Japanese. No abstract available.

PMID:
23356157
31.

Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease.

Hamada H, Suzuki H, Abe J, Suzuki Y, Suenaga T, Takeuchi T, Yoshikawa N, Shibuta S, Miyawaki M, Oishi K, Yamaga H, Aoyagi N, Iwahashi S, Miyashita R, Honda T, Onouchi Y, Terai M, Hata A.

Cytokine. 2012 Dec;60(3):681-5. doi: 10.1016/j.cyto.2012.08.006. Epub 2012 Sep 1.

PMID:
22944461
32.

The effectiveness of a multidisciplinary QI activity for accidental fall prevention: staff compliance is critical.

Ohde S, Terai M, Oizumi A, Takahashi O, Deshpande GA, Takekata M, Ishikawa R, Fukui T.

BMC Health Serv Res. 2012 Jul 12;12:197. doi: 10.1186/1472-6963-12-197.

33.

A genome-wide association study identifies three new risk loci for Kawasaki disease.

Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, Hamada H, Honda T, Suzuki H, Suenaga T, Takeuchi T, Yoshikawa N, Suzuki Y, Yasukawa K, Ebata R, Higashi K, Saji T, Kemmotsu Y, Takatsuki S, Ouchi K, Kishi F, Yoshikawa T, Nagai T, Hamamoto K, Sato Y, Honda A, Kobayashi H, Sato J, Shibuta S, Miyawaki M, Oishi K, Yamaga H, Aoyagi N, Iwahashi S, Miyashita R, Murata Y, Sasago K, Takahashi A, Kamatani N, Kubo M, Tsunoda T, Hata A, Nakamura Y, Tanaka T; Japan Kawasaki Disease Genome Consortium; US Kawasaki Disease Genetics Consortium.

Nat Genet. 2012 Mar 25;44(5):517-21. doi: 10.1038/ng.2220.

PMID:
22446962
34.

Intradermal nodular fasciitis.

Terai M, Oka M, Kunisada M, Kawakami F, Nishigori C.

Eur J Dermatol. 2012 Mar-Apr;22(2):285-6. doi: 10.1684/ejd.2012.1657. No abstract available.

PMID:
22265886
35.

Recalcitrant pruritic urticarial papules and plaques of pregnancy with a prolonged course after delivery.

Terai M, Oka M, Tsujimoto M, Kunisada M, Tada S, Bito T, Nishigori C.

Eur J Dermatol. 2012 Jan-Feb;22(1):136-7. doi: 10.1684/ejd.2011.1574. No abstract available.

PMID:
22155185
36.

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy.

Sato T, Terai M, Tamura Y, Alexeev V, Mastrangelo MJ, Selvan SR.

Immunol Res. 2011 Dec;51(2-3):170-82. doi: 10.1007/s12026-011-8262-6. Review.

PMID:
22139852
37.

ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.

Onouchi Y, Suzuki Y, Suzuki H, Terai M, Yasukawa K, Hamada H, Suenaga T, Honda T, Honda A, Kobayashi H, Takeuchi T, Yoshikawa N, Sato J, Shibuta S, Miyawaki M, Oishi K, Yamaga H, Aoyagi N, Iwahashi S, Miyashita R, Murata Y, Ebata R, Higashi K, Ozaki K, Sasago K, Tanaka T, Hata A.

Pharmacogenomics J. 2013 Feb;13(1):52-9. doi: 10.1038/tpj.2011.45. Epub 2011 Oct 11.

PMID:
21987091
38.

Interleukin 6 mediates production of interleukin 10 in metastatic melanoma.

Terai M, Eto M, Young GD, Berd D, Mastrangelo MJ, Tamura Y, Harigaya K, Sato T.

Cancer Immunol Immunother. 2012 Feb;61(2):145-155. doi: 10.1007/s00262-011-1084-5. Epub 2011 Aug 19.

PMID:
21853302
39.

[A case of corpus callosum splenium encephalopathy and 2009 influenza A/H1N1].

Kimura S, Yoneda C, Hashimoto N, Hamada H, Terai M.

Kansenshogaku Zasshi. 2011 May;85(3):272-4. Japanese.

PMID:
21706848
40.

Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin.

Suzuki H, Terai M, Hamada H, Honda T, Suenaga T, Takeuchi T, Yoshikawa N, Shibuta S, Miyawaki M, Oishi K, Yamaga H, Aoyagi N, Iwahashi S, Miyashita R, Onouchi Y, Sasago K, Suzuki Y, Hata A.

Pediatr Infect Dis J. 2011 Oct;30(10):871-6. doi: 10.1097/INF.0b013e318220c3cf.

PMID:
21587094
41.

Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine.

Mahipal A, Terai M, Berd D, Chervoneva I, Patel K, Mastrangelo MJ, Sato T.

Cancer Immunol Immunother. 2011 Jul;60(7):1039-45. doi: 10.1007/s00262-011-1019-1. Epub 2011 Apr 26.

PMID:
21519827
42.

Increased production of vascular endothelial growth factor-d and lymphangiogenesis in acute Kawasaki disease.

Ebata R, Abe J, Yasukawa K, Hamada H, Higashi K, Suwazono Y, Saito H, Terai M, Kohno Y.

Circ J. 2011;75(6):1455-62. Epub 2011 Apr 12.

43.

Early induction of interleukin-5 and peripheral eosinophilia in acute pneumonia in Japanese children infected by pandemic 2009 influenza A in the Tokyo area.

Terai M, Honda T, Yamamoto S, Yoshida M, Tsuchiya N, Moriyama Y, Matsui T, Tokutake S, Suzuki E, Shirato Y, Muto A, Hayashi K, Hamada H.

Microbiol Immunol. 2011 May;55(5):341-6. doi: 10.1111/j.1348-0421.2011.00320.x.

44.

Relationship between nursing workloads and patient safety incidents.

Nishizaki Y, Tokuda Y, Sato E, Kato K, Matsumoto A, Takekata M, Terai M, Watanabe C, Lim YY, Ohde S, Ishikawa R.

J Multidiscip Healthc. 2010 May 26;3:49-54.

45.

Dystrophin conferral using human endothelium expressing HLA-E in the non-immunosuppressive murine model of Duchenne muscular dystrophy.

Cui CH, Miyoshi S, Tsuji H, Makino H, Kanzaki S, Kami D, Terai M, Suzuki H, Umezawa A.

Hum Mol Genet. 2011 Jan 15;20(2):235-44. doi: 10.1093/hmg/ddq458. Epub 2010 Oct 14.

46.

Survey of pediatric ward hospitalization due to respiratory syncytial virus infection after the introduction of palivizumab to high-risk infants in Japan.

Kusuda S, Takahashi N, Saitoh T, Terai M, Kaneda H, Kato Y, Ohashi A, Watabe S, Joh-o K, Hirai K.

Pediatr Int. 2011 Jun;53(3):368-73. doi: 10.1111/j.1442-200X.2010.03249.x.

PMID:
20854284
47.

Common variants in CASP3 confer susceptibility to Kawasaki disease.

Onouchi Y, Ozaki K, Buns JC, Shimizu C, Hamada H, Honda T, Terai M, Honda A, Takeuchi T, Shibuta S, Suenaga T, Suzuki H, Higashi K, Yasukawa K, Suzuki Y, Sasago K, Kemmotsu Y, Takatsuki S, Saji T, Yoshikawa T, Nagai T, Hamamoto K, Kishi F, Ouchi K, Sato Y, Newburger JW, Baker AL, Shulman ST, Rowley AH, Yashiro M, Nakamura Y, Wakui K, Fukushima Y, Fujino A, Tsunoda T, Kawasaki T, Hata A, Nakamura Y, Tanaka T.

Hum Mol Genet. 2010 Jul 15;19(14):2898-906. doi: 10.1093/hmg/ddq176. Epub 2010 Apr 27.

48.

Distinctive clinical features of human bocavirus in children younger than 2 years.

Moriyama Y, Hamada H, Okada M, Tsuchiya N, Maru H, Shirato Y, Maeda Y, Hirose Y, Yoshida M, Omura Y, Honda T, Muto A, Hayashi K, Terai M.

Eur J Pediatr. 2010 Sep;169(9):1087-92. doi: 10.1007/s00431-010-1183-x. Epub 2010 Apr 10.

49.

CCN3 and bone marrow cells.

Katsube K, Ichikawa S, Katsuki Y, Kihara T, Terai M, Lau LF, Tamamura Y, Takeda S, Umezawa A, Sakamoto K, Yamaguchi A.

J Cell Commun Signal. 2009 Jun;3(2):135-45. doi: 10.1007/s12079-009-0059-1. Epub 2009 Jul 23.

50.

High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma.

Yamamoto A, Chervoneva I, Sullivan KL, Eschelman DJ, Gonsalves CF, Mastrangelo MJ, Berd D, Shields JA, Shields CL, Terai M, Sato T.

Radiology. 2009 Jul;252(1):290-8. doi: 10.1148/radiol.2521081252.

PMID:
19561263

Supplemental Content

Support Center